Xiaobo Wang

Colorimetric and Fluorescent Dual-Modality Sensing Platform Based on Fluorescent Nanozyme

Fengna Xi, Jie Chen, Yejian Wan, 2021, Frontiers in Chemistry.

Three-dimensional macroscopic graphene supported vertically-ordered mesoporous silica-nanochannel film for direct and ultrasensitive detection of uric acid in serum.

Fengna Xi, Jie Chen, Junjie Liu, 2022, Talanta.

Direct and sensitive detection of sulfide ions based on one-step synthesis of ionic liquid functionalized fluorescent carbon nanoribbons

Jun Liu, Yuting Qian, Jiyang Liu, 2019, RSC advances.

Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment

Qingfeng Li, C. Jin, D. Fu, 2021, Gut.

Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors

Bowen Liu, Lequn Li, Jie Chen, 2023, Frontiers in Oncology.

Serum Immune Biomarker Levels combined with Hepatitis B Virus Infection Status Predicts Early Recurrence of Early-Stage Hepatocellular Carcinoma with Microvascular Invasion after Liver Resection.

Lequn Li, Jie Chen, T. Bai, 2022, Acta chirurgica Belgica.

Laparoscopic pancreaticoduodenectomy for pancreatic cancer and concomitant intestinal malrotation: A case report.

Feixiang Wu, Xiaobo Wang, Lequn Li, 2023, Asian Journal of Surgery.

Multichannel Sonocatalysis Amplifiers Target IDH1‐Mutated Tumor Plasticity and Attenuate Ros Tolerance to Repress Malignant Cholangiocarcinoma

Jun Liu, Yan Liu, Qin Wang, 2023, Advanced Functional Materials.

Conversion surgery for initially unresectable hepatocellular carcinoma using lenvatinib combined with TACE plus PD-1 inhibitor: A real-world observational study.

Shao-long Lu, Jie Chen, T. Bai, 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Combined Effects of Anti-PD-L1 and Nanosonodynamic Therapy on HCC Immune Activation in Mice: An Investigation

Xiaobo Wang, Mengqi Zhang, Guanhua Qiu, 2024, International journal of nanomedicine.

TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study

Jie Chen, Xiaobo Wang, Lequn Li, 2024, BMC cancer.